Analyst Ratings for Acceleron Pharma (XLRN) [Sells]

XLRN Rating Summary

XLRN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on XLRN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $152.00 (+24.8%) * Over Last 12-Mos
Rating Score: 8.1 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
Like XLRN Ratings? Also take a look at BMY

XLRN Ratings News